John Alexander Bartlett, M.D.

Director of the AIDS Research and Treatment Center

Professor in the Medicine

Department:
Medicine

Division:
Infectious Diseases

Email:
jab5acpubdukeedu

Mailing Address:
Box 3238, DUMC
Durham, NC 27710

Telephone:
919-681-8043

Training:
M.D., University of Virginia School of Medicine

Last Updated:
January 21, 1999

Clinical Interests:
General infectious diseases, human immune deficiencies, HIV, AIDS

Research Interests:
My clinical investigation is focused on the pathogenesis and treatment of HIV infection and its complicastions, especially in resource-limited settings.

Key Words: HIV infection, AIDS, treatment strategies, treatment failure, co-infections, resource-limited settings

Publications:
1997 -- Bartlett JA, Hullette C. Central nervous system pneumocysostis in the acquired immune deficiency syndrome. Clinical Infectious Diseases. 25:82-85, 1997.

1997 -- Staszewski S, Hill AM, Bartlett JA, Eron JJ, Katlama C, Johnson J, Sawyer W, McDade H. Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials. AIDS. 11:477-483, 1997.

1997 -- Bartlett JA, Berry P, Bockman W, Johnson J, Quinn J, Graham S, DeMasi R, Alexander WJ. A placebo controlled trial of ranitidine in patients with early HIV infection. Journal of Infectious Diseases. 177:231-234, 1997.

1997 -- Ferrari G, Berend C, Ottinger J, Dodge R,Bartlett J, Toso J, Moody D, Tartaglia J, Cox W, Paoletti E, Weinhold K. Replication -defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiemcy virus-1 cytotoxic T lymphocytes present in infected patients: Implications for antigen-specific immunotherapy. Blood, (90) 6; 2406-2416, 1997.

1997 -- Hecht FM, Wheat J, Korzun AH, Hafner R, Skahan KJ, Larsen R, Limjoco MT, Simpson M, Schneider D, Keefer MC, Clark R, Lai KK, Jacobson JM, Squires K, Bartlett JA and Powderly W. Itraconazole maintenance treatment for histoplasmosis in AIDS: A prospective, multicenter trial. Journal of Immune Deficiency Syndromes and Human Retrovirology. 16:100-107, 1997.

-- Bartlett JA, Wasserman S, Hicks C, Dodge R, Weinhold K, Tacket C, Ketter N, Wittek A, Palker T, Haynes BF and the DATRI 010 Study Group. Safety and immunogenicity of C4V3 polyvalent synthetic peptides in HIV-infected HLA B7 positive subjects with CD4 cells > 500/mm3. Submitted to Journal of Infectious Diseases.

-- Bartlett JA, Berend C, Ottinger J, Tyler D, Petroni G, Petinelli C, Weinhold KJ. Co-administration of zidovudine and interleukin-2 increases absolute CD4+ cells in subjects with Walter Reed stage 2 HIV infection: Results of ACTG protocol 042. Submitted to Journal of Infectious Diseases.